Details about Ismo Erkki Olavi Linnosmaa

Access statistics for papers by Ismo Erkki Olavi Linnosmaa.

Last updated 2026-01-17. Update your information in the RePEc Author Service.

Short-id: pli751

Working Papers

2023

1. Economics of Healthcare Provider Altruism
   HERO Online Working Paper Series, University of Oslo, Health Economics Research Programme View citations (3)

2022

2. Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
   See also Journal Article Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer), The European Journal of Health Economics, Springer (2022) View citations (1) (2022)

2021

3. Do you prefer safety to social participation? Finnish population-based preference weights for the Adult Social Care Outcomes Toolkit (ASCOT) for service users
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (2)

2019

4. Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (13)
   See also Journal Article Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data, Journal of Health Economics, Elsevier (2019) View citations (15) (2019)
5. Pricing the Pharmaceuticals when the Ability to Pay Differs: Taking Vertical Equity Seriously
   CESifo Working Paper Series, CESifo View citations (1)

2012

6. Generic substitution policy, prices and market structure: evidence from a quasi-experiment in Finland
   Working Papers, VATT Institute for Economic Research View citations (1)

2006

7. Adaption of New Technologies and Costs of Health Care
   Discussion Papers, The Research Institute of the Finnish Economy

2003

8. Price Markups and R&D Inputs: The Pharmaceutical Industry in Finland and the USA
   Discussion Papers, The Research Institute of the Finnish Economy View citations (1)

2002

9. Price-Cost Margin in the Pharmaneutical Industry: Empirical Evidence from Finland
   Discussion Papers, The Research Institute of the Finnish Economy View citations (2)

Journal Articles

2024

1. Cost-effectiveness of a parenting program to reduce children’s behavioral problems among families receiving child protection services and other family support services – A randomized controlled trial
   Children and Youth Services Review, 2024, 158, (C)

2022

2. Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer)
   The European Journal of Health Economics, 2022, 23, (3), 357-374 View citations (1)
   See also Working Paper Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer), LSE Research Online Documents on Economics (2022) (2022)

2021

3. Choice, quality and patients’ experience: evidence from a Finnish physiotherapy service
   International Journal of Health Economics and Management, 2021, 21, (2), 229-245 View citations (1)

2020

4. Low risk, high reward? Repeated competitive biddings with multiple winners in health care
   The European Journal of Health Economics, 2020, 21, (4), 483-500 View citations (2)
5. Population-based preference weights for the Adult Social Care Outcomes Toolkit (ASCOT) for service users for Austria: Findings from a best-worst experiment
   Social Science & Medicine, 2020, 250, (C) View citations (2)

2019

6. Physician altruism and moral hazard: (no) Evidence from Finnish national prescriptions data
   Journal of Health Economics, 2019, 65, (C), 153-169 View citations (15)
   See also Working Paper Physician altruism and moral hazard: (no) evidence from Finnish national prescriptions data, LSE Research Online Documents on Economics (2019) View citations (13) (2019)

2017

7. Assessing the effects of price regulation and freedom of choice on quality: evidence from the physiotherapy market
   Health Economics Review, 2017, 7, (1), 1-16
8. Competition and quality in a physiotherapy market with fixed prices
   The European Journal of Health Economics, 2017, 18, (1), 97-117 View citations (1)
9. Does Competition Have an Effect on Price and Quality in Physiotherapy?
   Health Economics, 2017, 26, (10), 1278-1290 View citations (3)

2013

10. Market competition, ownership, payment systems and the performance of health care providers – a panel study among Finnish occupational health services providers
    Health Economics, Policy and Law, 2013, 8, (4), 477-510

2011

11. Public health care providers and market competition: the case of Finnish occupational health services
    The European Journal of Health Economics, 2011, 12, (1), 3-16 View citations (1)

2008

12. Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs
    The B.E. Journal of Economic Analysis & Policy, 2008, 8, (2), 37 View citations (1)

2005

13. European prices of newly launched reimbursable pharmaceuticals - a pilot study
    Health Policy, 2005, 74, (3), 235-246 View citations (5)

2004

14. Price-cost margin in the pharmaceutical industry
    The European Journal of Health Economics, 2004, 5, (2), 122-128 View citations (3)

Chapters

2000

1. Economics of dental services
   Chapter 24 in Handbook of Health Economics, 2000, vol. 1, pp 1251-1296 View citations (25)